KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Research & Development: 2010-2021

Historic Research & Development for TherapeuticsMD (TXMD) over the last 12 years, with Dec 2021 value amounting to $7.1 million.

  • TherapeuticsMD's Research & Development fell 30.72% to $1.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $5.5 million, marking a year-over-year decrease of 31.61%. This contributed to the annual value of $7.1 million for FY2021, which is 32.07% down from last year.
  • TherapeuticsMD's Research & Development amounted to $7.1 million in FY2021, which was down 32.07% from $10.4 million recorded in FY2020.
  • TherapeuticsMD's 5-year Research & Development high stood at $33.9 million for FY2017, and its period low was $7.1 million during FY2021.
  • For the 3-year period, TherapeuticsMD's Research & Development averaged around $12.4 million, with its median value being $10.4 million (2020).
  • Data for TherapeuticsMD's Research & Development shows a maximum YoY crashed of 47.29% (in 2020) over the last 5 years.
  • Over the past 5 years, TherapeuticsMD's Research & Development (Yearly) stood at $33.9 million in 2017, then fell by 19.36% to $27.3 million in 2018, then decreased by 27.50% to $19.8 million in 2019, then tumbled by 47.29% to $10.4 million in 2020, then slumped by 32.07% to $7.1 million in 2021.